237 related articles for article (PubMed ID: 37800288)
21. Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease.
Kavita ; Om H; Chand U; Kushawaha PK
Microbiol Res; 2024 Feb; 279():127550. PubMed ID: 38016379
[TBL] [Abstract][Full Text] [Related]
22. Postbiotics-A Step Beyond Pre- and Probiotics.
Żółkiewicz J; Marzec A; Ruszczyński M; Feleszko W
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32717965
[TBL] [Abstract][Full Text] [Related]
23. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A; Alexander SG; Martin S
Front Immunol; 2023; 14():1114499. PubMed ID: 37261348
[TBL] [Abstract][Full Text] [Related]
25. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
Wasilewski A; Zielińska M; Storr M; Fichna J
Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence.
Dhopatkar N; Keeler JL; Mutwalli H; Whelan K; Treasure J; Himmerich H
Psychoneuroendocrinology; 2023 Jan; 147():105959. PubMed ID: 36327759
[TBL] [Abstract][Full Text] [Related]
27. Interactions of probiotics and prebiotics with the gut microbiota.
Ballan R; Battistini C; Xavier-Santos D; Saad SMI
Prog Mol Biol Transl Sci; 2020; 171():265-300. PubMed ID: 32475525
[TBL] [Abstract][Full Text] [Related]
28. Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain-Gut-Microbiome Axis.
Chudzik A; Orzyłowska A; Rola R; Stanisz GJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356624
[TBL] [Abstract][Full Text] [Related]
29. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG
Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710
[TBL] [Abstract][Full Text] [Related]
30. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
[TBL] [Abstract][Full Text] [Related]
31. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.
Basson AR; Lam M; Cominelli F
Gastroenterol Clin North Am; 2017 Dec; 46(4):689-729. PubMed ID: 29173517
[TBL] [Abstract][Full Text] [Related]
32. Microbiomes in physiology: insights into 21st-century global medical challenges.
Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
[TBL] [Abstract][Full Text] [Related]
33. Overview on biotics development.
Roux AE; Langella P; Martin R
Curr Opin Biotechnol; 2024 Apr; 86():103073. PubMed ID: 38335705
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
Lim EY; Song EJ; Shin HS
J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
[TBL] [Abstract][Full Text] [Related]
35. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
36. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
38. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
Kapoor B; Gulati M; Gupta R; Singla RK
Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
40. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
Taghinezhad-S S; Mohseni AH; Fu X
J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
